(Q39627356)

13 September 2017

title

B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma (English)

1 reference

13 September 2017

Lei Wu

1

1 reference

13 September 2017

Wei-Wei Deng

2

1 reference

13 September 2017

Guang-Tao Yu

3

1 reference

13 September 2017

Liang Mao

4

1 reference

13 September 2017

Lin-Lin Bu

5

1 reference

13 September 2017

Si-Rui Ma

6

1 reference

13 September 2017

Bing Liu

7

1 reference

13 September 2017

Wen-Feng Zhang

8

1 reference

13 September 2017

Zhi-Jun Sun

9

1 reference

13 September 2017

publication date

6 July 2016

1 reference

Cancer Immunology, Immunotherapy

13 September 2017

published in

1 reference

13 September 2017

volume

65

1 reference

13 September 2017

issue

9

1 reference

13 September 2017

page(s)

1035-1045

1 reference

The mutational landscape of head and neck squamous cell carcinoma

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Cancer statistics in China, 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Oral cavity and oropharyngeal squamous cell carcinoma--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

The molecular biology of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Immunology and Immunotherapy of Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Immune checkpoint blockade: a common denominator approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

BTLA: a new inhibitory receptor with a B7-like ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Java Treeview--extensible visualization of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1867-9

10.1007/S00262-016-1867-9

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference